Figure S2 from A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Palbociclib does not increase RASi-driven cell death or affect RASi-driven phospho ERK inhibition